Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the fourth quarter and full year 2024. The company showcased a year of steady growth and operational …
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has announced it will release its full-year 2024 financial results on Monday, March 31, 2025. The company will also host a conference …
Palvella Therapeutics to Announce 2024 Financial Results and Host Investor Call on March 31, 2025 Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced progress in its Phase 1 clinical trial for OCU200, a novel biologic designed to treat diabetic macular edema (DME) and related eye conditions. …
Ocugen Advances OCU200 Clinical Trial Amid Promising Safety Results Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has reported its financial results for the fourth quarter and full year ending December 31, 2024, marking significant progress in its turnaround …
Verrica Pharmaceuticals Reports Q4 2024 Growth and Pipeline Progress Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced its plans to explore utilizing Molecular Envelope Technology (MET) for the intranasal delivery of a mRNA COVID vaccine. This innovative direction …
Virpax Pharmaceuticals Explores Intranasal mRNA Vaccine Delivery Using MET Read More
EXTON, PA — Innovative Solutions & Support (IS&S) (NASDAQ: ISSC) has announced that its Chief Executive Officer, Shahram Askarpour, and Chief Financial Officer, Jeffrey DiGiovanni, will participate in the Q1 …
Innovative Solutions & Support to Present at Q1 Investor Summit 2025 Read More BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced that findings from its dose range toxicity study for NES100, an innovative intranasal peptide for managing acute and chronic non-cancer pain, …
Virpax Pharmaceuticals to Present NES100 Toxicity Study at Major Toxicology Conference Read More
EXTON, PA — Dean W. Rivest, CEO of Omega Flex, Inc. (Nasdaq: OFLX), reported that the company’s net sales for 2024 totaled $101,681,000, compared to $111,465,000 in 2023, reflecting a …
Omega Flex Reports 2024 Financial Results: Sales and Income Decline Amid Market Challenges Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its fourth-quarter and full-year 2024 financial results, alongside significant progress across its clinical programs and regulatory initiatives. The company continues to drive …
Ocugen Reports 2024 Financial Results and Advances Gene Therapy Programs Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has released its 2024 financial results, detailing significant operational progress and strategic milestones, including the acquisition of Greenbrook TMS, FDA clearance for adolescent …
Neuronetics Reports 2024 Financial Results and Strategic Advances Read More